Your session is about to expire
← Back to Search
Tele-rheumatology for Rheumatic Diseases
N/A
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of rheumatic disease (e.g. rheumatoid arthritis, SLE)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 36-72 hours post visit after the first visit
Awards & highlights
Study Summary
This trial will study the effectiveness of tele-rheumatology visits for high risk people living with rheumatic and musculoskeletal disease, compared to in-person usual care.
Who is the study for?
This trial is for people with rheumatic diseases like rheumatoid arthritis or lupus who are stable enough to not require in-person visits. It's especially aimed at those using immunosuppressive drugs and from socially vulnerable populations. However, it excludes individuals with unstable conditions needing face-to-face care or those without access to a phone.Check my eligibility
What is being tested?
The study is testing the effectiveness of tele-rheumatology (remote medical consultations via phone or internet) compared to usual in-person care for patients with rheumatic diseases during the COVID-19 crisis. It's a randomized experiment aiming to provide safe and equitable care.See study design
What are the potential side effects?
Since this trial involves remote consultations rather than medication, traditional side effects aren't expected. However, there may be technical issues or communication barriers that could affect the quality of care received.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with a rheumatic disease like rheumatoid arthritis.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 36-72 hours post visit after the first visit
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36-72 hours post visit after the first visit
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Patient satisfaction
Secondary outcome measures
Patient preference
Trial Design
2Treatment groups
Experimental Treatment
Group I: Usual Care first visit and Tele-rheumatology second visitExperimental Treatment1 Intervention
Participants randomized to this visit will receive a usual care visit first.
Group II: Tele-rheumatology first visit and Usual Care second visitExperimental Treatment1 Intervention
Participants randomized to this visit will receive a tele-rheumatology visit first.
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,583 Previous Clinical Trials
2,279,392 Total Patients Enrolled
2 Trials studying Rheumatic Diseases
595 Patients Enrolled for Rheumatic Diseases
University of California, San FranciscoOTHER
2,503 Previous Clinical Trials
15,236,003 Total Patients Enrolled
1 Trials studying Rheumatic Diseases
65 Patients Enrolled for Rheumatic Diseases
Tulane UniversityOTHER
115 Previous Clinical Trials
225,850 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with a rheumatic disease like rheumatoid arthritis.I am expected to undergo procedures like joint injections in the doctor's office.I have a severe rheumatic condition requiring frequent doctor visits.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care first visit and Tele-rheumatology second visit
- Group 2: Tele-rheumatology first visit and Usual Care second visit
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this trial open to new participants?
"Yes, according to the clinicaltrials.gov website this trial is still in active recruitment mode. It was first posted on September 15th 2021 and last updated October 29 2022. A total of 320 participants will be selected from one location for this medical study."
Answered by AI
To what extent are participants included in this clinical study?
"Affirmative, the trial is currently recruiting. According to clinicaltrials.gov, it was first posted on September 15th 2021 and updated for the last time on October 29th 2022. To complete this study, 320 participants must be enrolled from a single medical site."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger